Recruiting Myasthenia Gravis Studies in Burlington
About Myasthenia Gravis Clinical Trials in Burlington
Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles responsible for breathing and movement. It occurs when communication between nerves and muscles is disrupted. Treatment includes medications that improve neuromuscular transmission and immunosuppressive therapies.
There are currently 1 myasthenia gravis clinical trials recruiting participants in Burlington, MA. These studies are seeking a combined 264 participants. Research is being sponsored by Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myasthenia Gravis Clinical Trials in Burlington — FAQ
Are there myasthenia gravis clinical trials in Burlington?
Yes, there are 1 myasthenia gravis clinical trials currently recruiting in Burlington, MA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Burlington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Burlington research site will contact you about next steps.
Are clinical trials in Burlington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Burlington studies also compensate for your time and travel.
What myasthenia gravis treatments are being tested?
The 1 active trials in Burlington are testing new therapies including novel drugs, biologics, and treatment approaches for myasthenia gravis.
Data updated March 2, 2026 from ClinicalTrials.gov